30493-08-4 Purity
96%
If you have any other questions or need other size, please get a quote.
Specification
Reference: [1]Simiti; Chindris
[Archiv der Pharmazie, 1972, vol. 305, # 7, p. 509 - 515]
Reference: [1]Archiv der Pharmazie,1975,vol. 308,p. 688 - 692
Reference: [1]Zhao; Scarlato; Armstrong
[Tetrahedron Letters, 1991, vol. 32, # 13, p. 1609 - 1612]
[2]Simiti; Chindriş
[Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft, 1971, vol. 304, # 6, p. 425 - 429]
[3]Current Patent Assignee: GLAXOSMITHKLINE PLC; DANA-FARBER CANCER INSTITUTE - WO2017/112838, 2017, A1
Location in patent: Paragraph 85
* For details of the synthesis route, please refer to the original source to ensure accuracy.